Towards the synthesis and delivery of a halogenated MCT1 substrate
<p>The monocarboxylate transporter 1 (MCT1) has received special attention as a potential therapeutic target in cancer thanks to its role in lactate shuttling. In breast cancer (BC), high MCT1 expression has been correlated with basal-like phenotype and a ‘triple-negative’ status, an aggressiv...
المؤلف الرئيسي: | Skaripa-Koukelli, Eirini |
---|---|
مؤلفون آخرون: | Vallis, K |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2019
|
الموضوعات: |
مواد مشابهة
-
Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review
حسب: Paul M. D. Gape, وآخرون
منشور في: (2024-03-01) -
Imaging and therapy with radionuclide labeled magnetic nanoparticles
حسب: Perihan Ünak
منشور في: (2008-12-01) -
Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
حسب: Iturrioz-Rodríguez N, وآخرون
منشور في: (2019-05-01) -
RNA nanostructures for targeted drug delivery and imaging
حسب: Laura Teodori, وآخرون
منشور في: (2024-12-01) -
RGD Forever!—Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences
حسب: Johannes Notni
منشور في: (2022-12-01)